|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Gonadotropin-relea sing hormone antagonists increase follicular fluid insulin-like growth factor-Ⅰ and vascular endothelial growth factor during ovarian stimulation cycles显示文摘 | Ferrari B Pezzuto A Barusi L | 2006 | Gynecol Endocrinol2006，22，6： | 1 |
| 2 | Profound luteinizing hormone suppression induces a deleterious follicular environment during assisted reproductive technology显示文摘 | Coppola F Potì ER Barusi L | | 0，，02： | 1 |
| 3 | Gonadotropin-releasing hormone antagonists increase follicular fluid insulin-like growth factor-Ⅰ and vascular endothelial growth factor during ovarian stimulation cycles显示文摘 | FERRARI B PEZZUTO A BARUSI L | 2006 | Gynecol Endocrinol2006，22，6： | 1 |
| 4 | Profound luteinizing hormone suppression induces a deleterious follicular environment during assisted reproduction technology 显示文摘 | Coppola F Pott ER Barusi L | 2003 | Fertil Steril2003，79，45： | 1 |
| 5 | Gonadotro- pin-releasing hormone antagonists increase follicular fluid insulin-like growth factor-I and vascular endothe- lial growth factor during ovarian stimulation cycles 显示文摘 | Parborell F Pezzuto A Barusi L | 2006 | Gynecol Endocrinol2006，22，6： | 1 |
| 6 | Profound luteinizing hormone suppression induces a deleterious follicular environment during assisted reproduction technology 显示文摘 | Coppola F Poti ER Barusi L | 2003 | Fertil Steril2003，79，2： | 1 |
| 7 | Follicular fluid vascular endothelial growth factor concentrations are increased during GnRH antagonist/ FSH ovarian stimulation cycles显示文摘 | B Ferrari A Pezzuto L Barusi | 2006 | European Journal of Obstetrics & Gynecology and Reproductive Biology2006，124，1： | 1 |
| 8 | Follicular fluid vascular endothelial growth factor concentrations are increased during GnRH antagonist/FSH ovarian stimulation cycles显示文摘 | B Ferrari A Pezzuto L Barusi | 2006 | European Journal of Obstetrics & Gynecology and Rep roductive Biology2006，124，1： | 1 |
| 9 | Gonadotropin-releasing hormone antagonists increase follicular fluid insulin-like growth factor-I and vascular endothelial growth factor during ovarian stimulation cycles显示文摘 | Ferrari B Pezzuto A Barusi L | 2006 | Gynecol Endocrinol2006，22，6： | 1 |
| 10 | Profound luteinizing hormone suppression induces a deleterious follicular environment during assisted reproductive technology显示文摘 | Coppola F Poti ER Barusi L | 2003 | Fertil Steril2003，79，2： | 1 |
| 11 | Follicular fluid vascular endothelial growth factor concentrations are increased during GnRH antagonist/FSH ovarian stimulation cycles显示文摘 | Pezzuto A Barusi L | 2006 | Eur J Obstet Gynecol Reprod Biol2006，124，1： | 1 |
| 12 | Follicular fluid vascular endothelial growth factor concentrations are increased during GnRH antagonist/FSH ovarian stimulation cycles显示文摘 | B Ferrari A Pezzuto L Barusi | 2006 | European Journal of Obstetrics & Gynecology and Reproductive Biology2006，124，1： | 1 |
| 13 | Gonadotropin-releasing hormoneantagonists increase follicular fluid insulin-like growth factor-I andvascular endothelial growth factor during ovarian stimulation cycles显示文摘 | Ferrari B Pezzuto A Barusi L | 2006 | Gynecol Endocrinol2006，22，6： | 1 |
| 14 | Profound luteinizing hormone suppression induces a deleterious follicular environment during assisted reproduction technology显示文摘 | Coppola F Potì ER Barusi L | 2003 | Fertil Steril2003，79，2： | 1 |
| 15 | Gonadotropin-releasing hormone antagonists increase follicular fluid insulin-like growth factor-1 and vscular endothelial growth factor during ovarian stimulation cycles显示文摘 | Ferrari B Pezzuto A Barusi L | 2006 | Gynecol Endocrinol2006，22，6： | 1 |
| 16 | Gonadotropin-releasing hormone antagonists increase follicular fluid insulin-like growth factor-Ⅰ and vascular endothelial growth factor during ovarian stimulation cycles显示文摘 | Ferrari B Pezzuto A Barusi L | 2006 | Gynecol Endocrinol2006，22，6： | 1 |
| 17 | 促性腺激素释放激素GnRH拮抗剂/FSH卵巢刺激周期中卵泡液血管内皮生长因子浓度增加显示文摘Background: The aim of this study was to investigate the effect of GnRH antagonists (GnRH-ant) on follicular fluid vascular endothelial growth factor (FF VEGF). Methods: Sixty women undergoing assisted reproduction were randomised (computer generated randomisation list) and assigned to two different GnRH analogue regimens: GnRH agonist (GnRH-a) (Group A; n = 30) and GnRH-ant (Group B; n = 30). Results: Mean (±SD) FF VEGF concentrations were 1598 ±612 pg/mL and 2906 ±1558 pg/mL for Groups A and B, respectively (p < 0.001). In the women treated with GnRH-ant, we found a statistically significant reduction in serum LH levels (1.72 ±0.74 IU/L in Group A versus 0.93 ±0.43 IU/L in Group B, p < 0.001), in serum oestradiol (E2) levels (1562.1 ±410.7 pg/mL in Group A versus 1214.67 ±779.9 pg/mL in Group B, p < 0.05), in FF E2 levels (1146 ±593 ng/mL in Group A versus 621 ±435 ng/mL in Group B, p < 0.05), and in FF androstenedione levels (136 ±55 ng/mL in Group A versus 78 ±31 ng/mL in Group B, p < 0.001), as well as a reduction in the number of pregnancies, though not statistically significant (23.3%in Group A versus 16.6%in Group B). Conclusion: The increase in FF VEGF levels in women treated with GnRH-ant might be explained by a suppression of LH and E2 levels. | Ferrari B. Pezzuto A. Barusi L. Coppola F. 朱磊 | 2006 | 世界核心医学期刊文摘(妇产科学分册)2006，0，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员